Chatbot Implementation In The Clinical Informed Consent Process

The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.

NCT Number	NCT07756515
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Informed Consent
Enrollment	100 participants
Start Date	2027-01-01
Primary Completion	2028-12-17 (estimated)
Study Completion	2031-12-17 (estimated)
Updated on ClinicalTrials.gov	2026-08-10